Epizyme, Inc.
Records under this name other than the patents Epizyme, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 127 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,630,961 | Arginine Methyltransferase Inhibitors and Uses Thereof now held by Magseis FF LLC In force · Medium confidence | In force | Medium confidence | |
| US 10,800,743 | Arginine Methyltransferase Inhibitors and Uses Thereof now held by Epizme, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 10,166,238 | EZH2 Inhibitors for Treating Lymphoma now held by Eisai R&D Management Co., Ltd. In force · High confidence | In force | High confidence | |
| US 10,653,693 | PRMT5 Inhibitors and Uses Thereof In force · High confidence | In force | High confidence | |
| US 11,642,347 | EZH2 Inhibitors for Treating Lymphoma now held by Eisai R&D Management Co., Ltd. In force · High confidence | In force | High confidence | |
| US 10,456,407 | Combination Therapy for Treating Cancer now held by Health Research, Inc. In force · High confidence | In force | High confidence | |
| US 10,112,968 | Inhibitors of Protein Methyltransferase DOT1L and Methods of Use Thereof Lapsed on the fee record Ended Oct 30, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 30, 2026 | Low confidence |
| US 10,106,510 | Substituted Isoxazoles for Treating Cancer Lapsed on the fee record Ended Oct 23, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 23, 2026 | Low confidence |
| US 10,098,888 | Substituted Benzene Compounds Lapsed on the fee record Ended Oct 16, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 16, 2026 | Low confidence |
| US 10,092,572 | Substituted Benzene Compounds Lapsed on the fee record Ended Oct 9, 2026 · High confidence | Lapsed on the fee record | Ended Oct 9, 2026 | High confidence |